Biểu đồ giá cổ phiếu IKT
IKT Cổ tức
Inhibikase Therapeutics Inc
$2.35
0.85%
$0.02
Khi đóng cửa: Jul 27, 16:00:00 GMT-4
$2.39
1.7%
$0.04
Phiên sau giờ: Jul 27, 17:41:21 GMT-4
Quay lại
Inhibikase Therapeutics Inc (IKT) Cổ tức
Thống kê chính
Giá đóng cửa trước
$2.33
Giá mở cửa
$2.36
Phạm vi ngày
$2.31 - $2.39
Phạm vi 52 tuần
$1.33 - $2.39
Khối lượng
507.3K
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
--
EPS (TTM)
-1.15
Vốn hóa thị trường
$315.5M
IKT là gì?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
